391 related articles for article (PubMed ID: 17132607)
1. Comparative immunotoxicity evaluation of amphotericin B and ABELCET, an amphotericin B lipid complex (ABLC).
Zhang Z; Lipman JM; Diener RM; Thomas P
Int J Toxicol; 2006; 25(6):487-92. PubMed ID: 17132607
[TBL] [Abstract][Full Text] [Related]
2. Safety evaluation of ABELCET, an amphotericin B lipid complex (ABLC): toxicity studies in rats.
Zhang Z; Diener RM; Lipman JM
Int J Toxicol; 2006; 25(4):285-94. PubMed ID: 16815817
[TBL] [Abstract][Full Text] [Related]
3. Study of the toxicity of a new lipid complex formulation of amphotericin B.
Larabi M; Pages N; Pons F; Appel M; Gulik A; Schlatter J; Bouvet S; Barratt G
J Antimicrob Chemother; 2004 Jan; 53(1):81-8. PubMed ID: 14657087
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the potential immunotoxicity of 3-monochloro-1,2-propanediol in Balb/c mice. I. Effect on antibody forming cell, mitogen-stimulated lymphocyte proliferation, splenic subset, and natural killer cell activity.
Lee JK; Byun JA; Park SH; Kim HS; Park JH; Eom JH; Oh HY
Toxicology; 2004 Nov; 204(1):1-11. PubMed ID: 15369844
[TBL] [Abstract][Full Text] [Related]
5. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.
Zhu XL; Chen AF; Lin ZB
J Ethnopharmacol; 2007 May; 111(2):219-26. PubMed ID: 17182202
[TBL] [Abstract][Full Text] [Related]
6. Genistein modulates splenic natural killer cell activity, antibody-forming cell response, and phenotypic marker expression in F(0) and F(1) generations of Sprague-Dawley rats.
Guo TL; White KL; Brown RD; Delclos KB; Newbold RR; Weis C; Germolec DR; McCay JA
Toxicol Appl Pharmacol; 2002 Jun; 181(3):219-27. PubMed ID: 12079431
[TBL] [Abstract][Full Text] [Related]
7. Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
Alexander BD; Dodds Ashley ES; Addison RM; Alspaugh JA; Chao NJ; Perfect JR
Transpl Infect Dis; 2006 Mar; 8(1):13-20. PubMed ID: 16623816
[TBL] [Abstract][Full Text] [Related]
8. Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis.
Sivak O; Bartlett K; Risovic V; Choo E; Marra F; Batty DS; Wasan KM
J Pharm Sci; 2004 Jun; 93(6):1382-9. PubMed ID: 15124198
[TBL] [Abstract][Full Text] [Related]
9. Amphotericin B lipid complex.
Rapp RP; Gubbins PO; Evans ME
Ann Pharmacother; 1997 Oct; 31(10):1174-86. PubMed ID: 9337444
[TBL] [Abstract][Full Text] [Related]
10. Induction of splenic T cell proliferation by lipid A in mice immunized with sheep red blood cells.
Mita A; Ohta H; Mita T
J Immunol; 1982 Apr; 128(4):1709-11. PubMed ID: 7037954
[TBL] [Abstract][Full Text] [Related]
11. Effect of 2,4-dicholorophenoxyacetic acid, trifluralin and triallate herbicides on immune function.
Blakley BR; Yole MJ; Brousseau P; Boermans H; Fournier M
Vet Hum Toxicol; 1998 Feb; 40(1):5-10. PubMed ID: 9467199
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-1 stimulation of lymphopoiesis.
Clark R; Strasser J; McCabe S; Robbins K; Jardieu P
J Clin Invest; 1993 Aug; 92(2):540-8. PubMed ID: 8349796
[TBL] [Abstract][Full Text] [Related]
13. Systemic immunosuppression following a single pharyngeal aspiration of 1,2:5,6-dibenzanthracene in female B6C3F1 mice.
Smith DC; Smith MJ; White KL
J Immunotoxicol; 2010; 7(3):219-31. PubMed ID: 20509767
[TBL] [Abstract][Full Text] [Related]
14. Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.
Drew RH; Dodds Ashley E; Benjamin DK; Duane Davis R; Palmer SM; Perfect JR
Transplantation; 2004 Jan; 77(2):232-7. PubMed ID: 14742987
[TBL] [Abstract][Full Text] [Related]
15. Correlation of suppressed natural killer cell activity with altered host resistance models in B6C3F1 mice.
Wilson SD; McCay JA; Butterworth LF; Munson AE; White KL
Toxicol Appl Pharmacol; 2001 Dec; 177(3):208-18. PubMed ID: 11749120
[TBL] [Abstract][Full Text] [Related]
16. Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model.
Cannon JP; Fiscella R; Pattharachayakul S; Garey KW; De Alba F; Piscitelli S; Edward DP; Danziger LH
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2112-7. PubMed ID: 12714650
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and activity of dipeptides, linked to targeting ligands, as specific NK cell enhancers.
Abbott SD; Gagnon L; Lagraoui M; Kadhim S; Attardo G; Zacharie B; Penney CL
J Med Chem; 1998 May; 41(11):1909-26. PubMed ID: 9599240
[TBL] [Abstract][Full Text] [Related]
18. Immunologic effects of neonatal infection with mouse thymic virus.
Cohen PL; Cross SS; Mosier DE
J Immunol; 1975 Sep; 115(3):706-10. PubMed ID: 168265
[TBL] [Abstract][Full Text] [Related]
19. Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain.
Aguado JM; Lumbreras C; González-Vidal D;
Clin Microbiol Infect; 2004 Sep; 10(9):785-90. PubMed ID: 15355408
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the immunotoxicity of benzoporphyrin derivative (BPD-MA) in mice.
Waterfield JD; Fairhurst M; Waterfield EM; Norbury KC
Immunopharmacol Immunotoxicol; 1997 Feb; 19(1):89-103. PubMed ID: 9049661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
